From Seekingalpha · · 40s
TL;DR: MiniMed's Product Cycle Hides Split-Off Hangover
MiniMed's split-off obscures product-cycle progress despite strong Q1 growth.
MiniMed Group's Q1 organic growth accelerated to 15.8% with new U.S. pump volumes rising over 20% as it shifts from share donor to share taker. MiniMed's split-off obscures product-cycle progress despite strong Q1 growth. MiniMed Group's Q1 organic growth accelerated to 15.8% with new U.S. pump volumes rising over 20%.
- MiniMed Group
- Product Cycle Progress
- Share Taker Shift
Read the story version — the same reporting as a swipeable deck of 3 cards.
